These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1292 related articles for article (PubMed ID: 25626035)
1. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. Siddiqui MM; Rais-Bahrami S; Turkbey B; George AK; Rothwax J; Shakir N; Okoro C; Raskolnikov D; Parnes HL; Linehan WM; Merino MJ; Simon RM; Choyke PL; Wood BJ; Pinto PA JAMA; 2015 Jan; 313(4):390-7. PubMed ID: 25626035 [TBL] [Abstract][Full Text] [Related]
2. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839 [TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939 [TBL] [Abstract][Full Text] [Related]
4. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen. Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370 [TBL] [Abstract][Full Text] [Related]
5. Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Biopsy Improves but Does Not Replace Standard Template Biopsy for the Detection of Prostate Cancer. Hanna N; Wszolek MF; Mojtahed A; Nicaise E; Wu B; Gelpi-Hammerschmidt FJ; Salari K; Dahl DM; Blute ML; Harisinghani M; Feldman AS J Urol; 2019 Nov; 202(5):944-951. PubMed ID: 31144593 [TBL] [Abstract][Full Text] [Related]
6. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial. Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer. Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846 [TBL] [Abstract][Full Text] [Related]
9. MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men. Yarlagadda VK; Lai WS; Gordetsky JB; Porter KK; Nix JW; Thomas JV; Rais-Bahrami S Diagn Interv Radiol; 2018; 24(3):115-120. PubMed ID: 29770762 [TBL] [Abstract][Full Text] [Related]
10. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes. Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001 [TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study. Lee DJ; Recabal P; Sjoberg DD; Thong A; Lee JK; Eastham JA; Scardino PT; Vargas HA; Coleman J; Ehdaie B J Urol; 2016 Sep; 196(3):697-702. PubMed ID: 27038768 [TBL] [Abstract][Full Text] [Related]
12. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676 [TBL] [Abstract][Full Text] [Related]
13. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies. Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061 [TBL] [Abstract][Full Text] [Related]
14. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies. Filson CP; Natarajan S; Margolis DJ; Huang J; Lieu P; Dorey FJ; Reiter RE; Marks LS Cancer; 2016 Mar; 122(6):884-92. PubMed ID: 26749141 [TBL] [Abstract][Full Text] [Related]
15. Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naïve men. Shoji S; Hiraiwa S; Ogawa T; Kawakami M; Nakano M; Hashida K; Sato Y; Hasebe T; Uchida T; Tajiri T Int J Urol; 2017 Apr; 24(4):288-294. PubMed ID: 28222486 [TBL] [Abstract][Full Text] [Related]
16. Multiparametric ultrasound-targeted biopsy compares favorably to multiparametric MRI-transrectal ultrasound fusion-targeted biopsy on initial biopsy of men at risk for prostate cancer. Fulgham PF World J Urol; 2018 May; 36(5):713-718. PubMed ID: 29368230 [TBL] [Abstract][Full Text] [Related]
17. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346 [TBL] [Abstract][Full Text] [Related]
18. Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy. Kenigsberg AP; Renson A; Rosenkrantz AB; Huang R; Wysock JS; Taneja SS; Bjurlin MA Eur Urol Oncol; 2018 Oct; 1(5):418-425. PubMed ID: 31158081 [TBL] [Abstract][Full Text] [Related]
19. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer. Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210 [TBL] [Abstract][Full Text] [Related]
20. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]